Metabolic Engineering of Chromosomally Integrated Bacillus licheniformis for the Efficient Biosynthesis of Pseudouridine

Abstract Pseudouridine (Ψ) is extensively applied in the medical domain, particularly for mRNA vaccines. However, the production titers of the existing engineered strains remain insufficient to meet market demands. In this study, a multilevel metabolic engineering strategy was implemented to achieve high-level Ψ production in Bacillus licheniformis. First, heterologous ΨMP glycosidase was introduced and engineered, resulting in Ψ production of 1.8 g/L. Subsequently, yqfW and yfnB with strong dephosphorylation for ΨMP were overexpressed, elevating Ψ production by 179.3%. Furthermore, carbon flux was redirected toward intracellular ribose-5-phosphate supply via attenuated pgi expression, increasing Ψ production to 12.1 g/L. Finally, scale-up cultivation in a 5 L bioreactor achieved a Ψ titer of 38.6 g/L, with molar conversion rates of 96.5% from uracil and 31.5% from glucose. These results represent the highest Ψ production level reported in Bacillus species to date, providing a robust foundation for the biosynthesis and industrial application of pyrimidine nucleosides.

Authors

Institutions

Publication Details

Journal
ACS Synthetic Biology
Published
2026-11-12
DOI
https://doi.org/10.1021/acssynbio.6c00462
Primary Topic
Microbial Metabolic Engineering and Bioproduction
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metabolic Engineering of Chromosomally Integrated Bacillus licheniformis for the Efficient Biosynthesis of Pseudouridine

Shouwen Chen, Yangyang Zhan, Dongbo Cai, Zhifan Yang et al.
ACS Synthetic Biology
Microbial Metabolic Engineering and Bioproduction
article

Metabolic Engineering of Chromosomally Integrated Bacillus licheniformis for the Efficient Biosynthesis of Pseudouridine

Shouwen Chen, Yangyang Zhan, Dongbo Cai, Zhifan Yang, Hui Tian, Xujie Li, Lunshuai Han, Xin Ma, Yi Zhou
article en

Abstract

Abstract Pseudouridine (Ψ) is extensively applied in the medical domain, particularly for mRNA vaccines. However, the production titers of the existing engineered strains remain insufficient to meet market demands. In this study, a multilevel metabolic engineering strategy was implemented to achieve high-level Ψ production in Bacillus licheniformis. First, heterologous ΨMP glycosidase was introduced and engineered, resulting in Ψ production of 1.8 g/L. Subsequently, yqfW and yfnB with strong dephosphorylation for ΨMP were overexpressed, elevating Ψ production by 179.3%. Furthermore, carbon flux was redirected toward intracellular ribose-5-phosphate supply via attenuated pgi expression, increasing Ψ production to 12.1 g/L. Finally, scale-up cultivation in a 5 L bioreactor achieved a Ψ titer of 38.6 g/L, with molar conversion rates of 96.5% from uracil and 31.5% from glucose. These results represent the highest Ψ production level reported in Bacillus species to date, providing a robust foundation for the biosynthesis and industrial application of pyrimidine nucleosides.

ACS Synthetic Biology
Hubei University (CN)
National Natural Science Foundation of China
Microbial Metabolic Engineering and Bioproduction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon